Health & Environmental Research Online (HERO)


Print Feedback Export to File
7556916 
Journal Article 
Centrally acting skeletal muscle relaxants and associated drugs 
Waldman, HJ; , 
1994 
Yes 
Journal of Pain and Symptom Management
ISSN: 0885-3924 
ELSEVIER SCIENCE INC 
NEW YORK 
9 
7 
434-441 
English 
7822882 
WOS:A1994PQ16700002 
A review of available studies supports a role for muscle relaxants in the treatment of painful musculoskeletal disorders. The utility of these drugs is limited by sedation and other side effects, as well as by the potential for abuse and dependency. Other drugs can also be used in the treatment of muscle spasm, specifically diazepam, baclofen, dantrolene sodium, and quinine sulfate. The pharmacology of the muscle relaxants and these other agents is discussed and practical suggestions for use are offered. 
central nervous system disorder; muscle spasm; musculoskeletal pain; Skeletal muscle relaxant; spasticity; trigeminal neuralgia; baclofen; carisoprodol; chlorphenesin carbamate; chlorzoxazone; cyclobenzaprine; dantrolene; diazepam; meprobamate; metaxalone; methocarbamol; norgesic; norgesic forte; orphenadrine; orphenadrine citrate; quinine; quinine sulfate; robaxisal; unclassified drug; drowsiness; drug dependence; drug efficacy; drug half life; drug mechanism; drug withdrawal; gastrointestinal symptom; human; muscle relaxation; muscle spasm; oral drug administration; rash; review; skeletal muscle; somnolence; Animal; Human; Muscle Relaxants, Central; Muscle Spasticity; Muscle, Skeletal; Spasm 
Other
• Harmful Algal Blooms- Health Effects
     April 2021 Literature Search
          Scopus